Cargando…
Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma
The majority of studies report that liver kinase B1 (LKB1) acts as a tumor suppressor by inhibiting cell proliferation and metastasis. The present study investigated the expression pattern of LKB1 in 2 cohorts of paired hepatocellular carcinoma (HCC) and analogous non-cancerous tissues (ANT). The re...
Autores principales: | Tan, Xiaolong, Liao, Zhibin, Liang, Huifang, Chen, Xiaoping, Zhang, Bixiang, Chu, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192789/ https://www.ncbi.nlm.nih.gov/pubmed/30226588 http://dx.doi.org/10.3892/ijo.2018.4556 |
Ejemplares similares
-
Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma
por: Li, Bin-Kui, et al.
Publicado: (2014) -
miR-631 Inhibits Intrahepatic Metastasis of Hepatocellular Carcinoma by Targeting PTPRE
por: Chen, Bingqing, et al.
Publicado: (2020) -
A micropeptide JunBP regulated by TGF-β promotes hepatocellular carcinoma metastasis
por: Zhang, Hongwei, et al.
Publicado: (2022) -
Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma
por: Li, Jun, et al.
Publicado: (2018) -
Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2020)